These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2434022)

  • 21. Polycyclic peptide and glycopeptide antibiotics and their derivatives as inhibitors of HIV entry.
    Preobrazhenskaya MN; Olsufyeva EN
    Antiviral Res; 2006 Sep; 71(2-3):227-36. PubMed ID: 16720053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Isolation and identification of antibiotics produced by Actinoplanes brasiliensis INA 3802].
    Katrukha GS; Fedorova GB; Arkhangel'skaia NM; Iassein M; Laĭko AV; Trifonova ZhP
    Antibiot Khimioter; 1999; 44(5):6-11. PubMed ID: 10483498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cationomycin, a new polyether ionophore antibiotic produced by Actinomadura Nov. sp.
    Nakamura G; Kobayashi K; Sakurai T; Isono K
    J Antibiot (Tokyo); 1981 Nov; 34(11):1513-4. PubMed ID: 7319913
    [No Abstract]   [Full Text] [Related]  

  • 24. Epoxomicin, a new antitumor agent of microbial origin.
    Hanada M; Sugawara K; Kaneta K; Toda S; Nishiyama Y; Tomita K; Yamamoto H; Konishi M; Oki T
    J Antibiot (Tokyo); 1992 Nov; 45(11):1746-52. PubMed ID: 1468981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Source of antibiotics other than Streptomyces.
    Nara T; Kawamoto I; Okachi R; Oka T
    Jpn J Antibiot; 1977 Dec; 30 Suppl():174-89. PubMed ID: 349190
    [No Abstract]   [Full Text] [Related]  

  • 26. [New trends in studies of the pharmacologic activity of microbial metabolites].
    Chmiel A
    Postepy Hig Med Dosw; 1989; 43(1):119-60. PubMed ID: 2697872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β-Lactam and glycopeptide antibiotics: first and last line of defense?
    Jovetic S; Zhu Y; Marcone GL; Marinelli F; Tramper J
    Trends Biotechnol; 2010 Dec; 28(12):596-604. PubMed ID: 20970210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A chemoenzymatic approach to glycopeptide antibiotics.
    Lin H; Walsh CT
    J Am Chem Soc; 2004 Nov; 126(43):13998-4003. PubMed ID: 15506762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycopeptide antibiotics.
    Parenti F
    J Clin Pharmacol; 1988 Feb; 28(2):136-40. PubMed ID: 3283178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kibdelins, novel glycopeptide antibiotics. I. Discovery, production, and biological evaluation.
    Shearer MC; Giovenella AJ; Grappel SF; Hedde RD; Mehta RJ; Oh YK; Pan CH; Pitkin DH; Nisbet LJ
    J Antibiot (Tokyo); 1986 Oct; 39(10):1386-94. PubMed ID: 3781909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characterization of some bromine analogs of the glycopeptide antibiotic actaplanin.
    Huber FM; Michel KH; Hunt AH; Martin JW; Molloy RM
    J Antibiot (Tokyo); 1988 Jun; 41(6):798-801. PubMed ID: 3403374
    [No Abstract]   [Full Text] [Related]  

  • 32. [Nonpolyene macrolide antibiotics].
    Navashin SM; Kuznetsova SM; Nikolaeva TI; Rozenfel'd GS
    Antibiotiki; 1981 Feb; 26(2):120-34. PubMed ID: 7011207
    [No Abstract]   [Full Text] [Related]  

  • 33. Harnessing the synthetic capabilities of glycopeptide antibiotic tailoring enzymes: characterization of the UK-68,597 biosynthetic cluster.
    Yim G; Kalan L; Koteva K; Thaker MN; Waglechner N; Tang I; Wright GD
    Chembiochem; 2014 Nov; 15(17):2613-23. PubMed ID: 25255985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Eremomycin--a new antibiotic from the cyclic glycopeptide group].
    Gauze GF; Brazhnikova MG; Laĭko AV; Sveshnikova MA; Preobrazhenskaia TP
    Antibiot Med Biotekhnol; 1987 Aug; 32(8):571-6. PubMed ID: 3674837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The structure and mode of action of glycopeptide antibiotics of the vancomycin group.
    Barna JC; Williams DH
    Annu Rev Microbiol; 1984; 38():339-57. PubMed ID: 6388496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precursor-directed biosynthesis for the generation of novel glycopetides.
    Stegmann E; Bischoff D; Kittel C; Pelzer S; Puk O; Recktenwald J; Weist S; Süssmuth R; Wohlleben W
    Ernst Schering Res Found Workshop; 2005; (51):215-32. PubMed ID: 15645723
    [No Abstract]   [Full Text] [Related]  

  • 37. Oritavancin: a new avenue for resistant Gram-positive bacteria.
    Mercier RC; Hrebickova L
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):325-32. PubMed ID: 15954849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chemical modification of glycopeptide antibiotics].
    Pavlov AIu; Preobrazhenskaia MN
    Bioorg Khim; 1998 Sep; 24(9):644-62. PubMed ID: 9813730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical and cost-effective manufacturing route for the synthesis of a β-lactamase inhibitor.
    Miller SP; Zhong YL; Liu Z; Simeone M; Yasuda N; Limanto J; Chen Z; Lynch J; Capodanno V
    Org Lett; 2014 Jan; 16(1):174-7. PubMed ID: 24329136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of glycopeptide antibiotics on human phagocyte activity].
    Fietta A; Sacchi F; Bersani C; De Rose V; Grassi F; Gialdroni Grassi G
    G Ital Chemioter; 1982; 29(1):11-4. PubMed ID: 6224719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.